Cargando…
Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models
Niemann–Pick disease type C (NPC) is an autosomal recessive disorder with progressive neurodegeneration. Although the causative genes were previously identified, NPC has unclear pathophysiological aspects, and patients with NPC present various symptoms and onset ages. However, various novel biomarke...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648601/ https://www.ncbi.nlm.nih.gov/pubmed/37958627 http://dx.doi.org/10.3390/ijms242115642 |
_version_ | 1785135376190406656 |
---|---|
author | Miyoshi, Keitaro Hishinuma, Eiji Matsukawa, Naomi Shirasago, Yoshitaka Watanabe, Masahiro Sato, Toshihiro Sato, Yu Kumondai, Masaki Kikuchi, Masafumi Koshiba, Seizo Fukasawa, Masayoshi Maekawa, Masamitsu Mano, Nariyasu |
author_facet | Miyoshi, Keitaro Hishinuma, Eiji Matsukawa, Naomi Shirasago, Yoshitaka Watanabe, Masahiro Sato, Toshihiro Sato, Yu Kumondai, Masaki Kikuchi, Masafumi Koshiba, Seizo Fukasawa, Masayoshi Maekawa, Masamitsu Mano, Nariyasu |
author_sort | Miyoshi, Keitaro |
collection | PubMed |
description | Niemann–Pick disease type C (NPC) is an autosomal recessive disorder with progressive neurodegeneration. Although the causative genes were previously identified, NPC has unclear pathophysiological aspects, and patients with NPC present various symptoms and onset ages. However, various novel biomarkers and metabolic alterations have been investigated; at present, few comprehensive proteomic alterations have been reported in relation to NPC. In this study, we aimed to elucidate proteomic alterations in NPC and perform a global proteomics analysis for NPC model cells. First, we developed two NPC cell models by knocking out NPC1 using CRISPR/Cas9 (KO1 and KO2). Second, we performed a label-free (LF) global proteomics analysis. Using the LF approach, more than 300 proteins, defined as differentially expressed proteins (DEPs), changed in the KO1 and/or KO2 cells, while the two models shared 35 DEPs. As a bioinformatics analysis, the construction of a protein–protein interaction (PPI) network and an enrichment analysis showed that common characteristic pathways such as ferroptosis and mitophagy were identified in the two model cells. There are few reports of the involvement of NPC in ferroptosis, and this study presents ferroptosis as an altered pathway in NPC. On the other hand, many other pathways and DEPs were previously suggested to be associated with NPC, supporting the link between the proteome analyzed here and NPC. Therapeutic research based on these results is expected in the future. |
format | Online Article Text |
id | pubmed-10648601 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106486012023-10-27 Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models Miyoshi, Keitaro Hishinuma, Eiji Matsukawa, Naomi Shirasago, Yoshitaka Watanabe, Masahiro Sato, Toshihiro Sato, Yu Kumondai, Masaki Kikuchi, Masafumi Koshiba, Seizo Fukasawa, Masayoshi Maekawa, Masamitsu Mano, Nariyasu Int J Mol Sci Article Niemann–Pick disease type C (NPC) is an autosomal recessive disorder with progressive neurodegeneration. Although the causative genes were previously identified, NPC has unclear pathophysiological aspects, and patients with NPC present various symptoms and onset ages. However, various novel biomarkers and metabolic alterations have been investigated; at present, few comprehensive proteomic alterations have been reported in relation to NPC. In this study, we aimed to elucidate proteomic alterations in NPC and perform a global proteomics analysis for NPC model cells. First, we developed two NPC cell models by knocking out NPC1 using CRISPR/Cas9 (KO1 and KO2). Second, we performed a label-free (LF) global proteomics analysis. Using the LF approach, more than 300 proteins, defined as differentially expressed proteins (DEPs), changed in the KO1 and/or KO2 cells, while the two models shared 35 DEPs. As a bioinformatics analysis, the construction of a protein–protein interaction (PPI) network and an enrichment analysis showed that common characteristic pathways such as ferroptosis and mitophagy were identified in the two model cells. There are few reports of the involvement of NPC in ferroptosis, and this study presents ferroptosis as an altered pathway in NPC. On the other hand, many other pathways and DEPs were previously suggested to be associated with NPC, supporting the link between the proteome analyzed here and NPC. Therapeutic research based on these results is expected in the future. MDPI 2023-10-27 /pmc/articles/PMC10648601/ /pubmed/37958627 http://dx.doi.org/10.3390/ijms242115642 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Miyoshi, Keitaro Hishinuma, Eiji Matsukawa, Naomi Shirasago, Yoshitaka Watanabe, Masahiro Sato, Toshihiro Sato, Yu Kumondai, Masaki Kikuchi, Masafumi Koshiba, Seizo Fukasawa, Masayoshi Maekawa, Masamitsu Mano, Nariyasu Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models |
title | Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models |
title_full | Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models |
title_fullStr | Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models |
title_full_unstemmed | Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models |
title_short | Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models |
title_sort | global proteomics for identifying the alteration pathway of niemann–pick disease type c using hepatic cell models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648601/ https://www.ncbi.nlm.nih.gov/pubmed/37958627 http://dx.doi.org/10.3390/ijms242115642 |
work_keys_str_mv | AT miyoshikeitaro globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT hishinumaeiji globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT matsukawanaomi globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT shirasagoyoshitaka globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT watanabemasahiro globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT satotoshihiro globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT satoyu globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT kumondaimasaki globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT kikuchimasafumi globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT koshibaseizo globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT fukasawamasayoshi globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT maekawamasamitsu globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels AT manonariyasu globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels |